Open AccessRituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
Author(s) -
Johannes Waiser,
Michael Duerr,
Constanze Schönemann,
Birgit Rudolph,
Kaiyin Wu,
Fabian Halleck,
Klemens Budde,
Nils Lachmann
Publication year - 2016
Publication title -
transplantation direct
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.648
H-Index - 9
ISSN - 2373-8731
DOI - 10.1097/txd.0000000000000604
Subject(s) - medicine , rituximab , bortezomib , plasmapheresis , group b , renal function , urology , regimen , proteinuria , gastroenterology , creatinine , antibody , surgery , immunology , kidney , multiple myeloma